Ruth M. Farrell, MD

Appointed
2006

Education & Fellowships

Fellowship - Johns Hopkins Hospital
Bioethics/Health Policy
Baltimore, MD
2006

Residency - University Hospitals of Cleveland
OB/GYN
Cleveland, OH
2004

Internship - University of Chicago Hospitals
OB/GYN
Chicago, IL
2001

Medical Education - Case Western Reserve University School of Medicine
Cleveland, OH
2000

Graduate School - Case Western Reserve University School of Medicine
Bioethics
Cleveland, OH
1996

Undergraduate - University of Chicago
Philosophy
Chicago, IL
1993

Additional Training

• American College of Obstetricians and GynecologistsLeadership Institute,
  
  Harvard Kennedy School Women and Power: Leadership in the 21st Century
  
  Case Western Reserve University School of Medicine FLEX Program
  
  Cleveland Clinic Women’s Physician and Professional Staff Accelerated Development Program
  
  Greenwall Fellowship of Bioethics and Health Policy, Johns Hopkins University and Georgetown University, Baltimore, Maryland
  
  Reproductive Policy Fellow, Genetics and Public Policy Center, Washington, DC
  
  J. Benjamin Younger Fellow of Public Policy, American Society for Reproductive Medicine, Washington, DC

Professional Highlights

• OB/GYN and Women's Health Institute, Vice Chair of Research
• Associate Professor of Surgery, Case Western Reserve University
• Associate Editor of the Cleveland Clinic Journal of Medicine
• Member of the American Congress of Obstetricians and Gynecologists (ACOG) Committee on Genetics
• Member of the American Society for Reproductive Medicine (ASRM ) Ethics Committee
• Past Member of the American Congress of Obstetricians and Gynecologists (ACOG) Committee on Ethics, Committee on Practice Bulletins, Committee on Gynecologic Practice
• Past Member of the Therapeutic Data Safety and Monitoring Board of the Division of AIDS, National Institute for Allergy and Infectious Diseases (NIAID)
• Past member of the Cleveland Clinic Ethics Committee
• Past chair and member of the Cleveland Clinic Hillcrest Hospital Ethics Committee

Certifications

• Obstetrics and Gynecology

Specialty Interests

Adolescent and women's reproductive health, medical gynecology, clinical research, ethics, reproductive ethics and health policy Adolescent health, bioethics of women's health, general gynecology, health policy of women's health

Awards & Honors

• Fellow of the American Gynecologic and Obstetrical Society
• CTSA KL2 Scholar/Multidisciplinary Clinical Research Training Program Grant
• Junior Career Development Award, Women Faculty of the School of Medicine, Case Western Reserve University
• Janet M. Glasgow Honorable Citation, American Medical Women’s Association

Memberships

• American College of Obstetricians and Gynecologists
• American Society for Bioethics and Humanities
• Cleveland Society for Obstetricians and Gynecologists
• American Institute for Ultrasound Medicine

See publications for Ruth M. Farrell, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 6/27/2024, Dr. Farrell has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.